Cefpirome
Jump to navigation
Jump to search
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C22H22N6O5S2 |
Molar mass | 514.58 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Cefpirome is a fourth-generation cephalosporin. Trade names include Cefrom, Keiten, Broact, and Cefir. Cefpirome is considered highly active against Gram-negative bacteria, including Pseudomonas aeruginosa, and Gram-positive bacteria.[citation needed]
Spectrum of bacterial susceptibility and resistance
Bacteroides fragilis, enterococci, Pseudomonas spp. and staphylococci are resistant to cefpirome sulfate, and some Haemophilus spp. and pneumococci have developed resistance to it to varying degrees.[1]
References
- ^ "Cefpirome Sulfate spectrum of bacterial susceptibility and Resistance" (PDF). Archived from the original (PDF) on 3 March 2016. Retrieved 10 April 2012.
Categories:
- Articles with short description
- Short description matches Wikidata
- Articles with changed ChemSpider identifier
- Articles with changed EBI identifier
- Articles with changed InChI identifier
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- All articles with unsourced statements
- Articles with unsourced statements from January 2023
- Cephalosporin antibiotics
- Thiazoles
- Ketoximes
- All stub articles
- Antibiotic stubs